Skip to main content
Fig. 2 | Breast Cancer Research

Fig. 2

From: Prognostic value of PAM50 and risk of recurrence score in patients with early-stage breast cancer with long-term follow-up

Fig. 2

Kaplan-Meier plots of breast cancer-specific survival (BCSS) (a–c) and distant disease-free survival DDFS (d–f) according to PAM50 subtypes in all 653 patients (a, d), patients with no adjuvant treatment (b, e), and patients with adjuvant treatment (c, f). p Values were derived from log-rank tests. HER2 Human epidermal growth factor receptor 2

Back to article page

Breast Cancer Research

ISSN: 1465-542X

Contact us